Contributor:

Sophie J. Bakri, MD

Educating the Next Generation of Surgeons During COVID-19

R.V. Paul Chan, MD, MSc, MBA, John Kitchens, MD, Julia Haller, MD, Sophie Bakri, MD

What Evidence Makes EYP-1901 a Promising Treatment for Wet AMD and DME?

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

Patient Selection for EYP-1901

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

Reinjection Criteria

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

Wet AMD and DME Therapy in Development

Sophie Bakri, MD; Durga S. Borkar, MD, MMCi; and Jayanth Sridhar, MD

What is EYP-1901 (DURAVYU™, (vorolanib intravitreal insert))?

Sophie Bakri, MD; Durga S. Borkar, MD, MMCi; and Jayanth Sridhar, MD

How May Tolerance for Subretinal Fluid Change Given Sustained-Release EYP-1901?

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

How Can a Multi-MOA Approach Benefit the Management of Wet AMD?

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

TKIs: How Do They Work?

Sophie Bakri, MD; Durga S. Borkar, MD, MMCi; and Jayanth Sridhar, MD

Why Do Real-World Wet AMD Outcomes Differ From Those Seen in Clinical Trials?

Sophie Bakri, MD; Durga S. Borkar, MD, MMCi; and Jayanth Sridhar, MD

Frothing Vitrector

Sophie J. Bakri, MD

Difficult Hyaloid

Sophie J. Bakri, MD

Infusion Cannula

Sophie J. Bakri, MD

Suprachoroidal Hemorrhage

Sophie J. Bakri, MD

Back to Practice: Educating the Next Generation of Surgeons During COVID-19

John Kitchens, MD; Sophie Bakri, MD; Julia Haller, MD; and R.V. Paul Chan, MD, MSc, MBA